July 4, 2022
Following its global acquisition of Zogenix earlier this year, Belgian drug maker UCB absorbed the Japan operations of the California-based biotech, effective July 1. In March this year, UCB acquired Zogenix, making the US company its wholly-owned subsidiary. In line...read more